Report an error   


Submitted: 16 May 2007 Modified: 15 February 2014
HERDIN Record #: PCHRDPC051609

Essential hypertension 2003: A tale of changing concepts and continuum of controversies.

Homobono B. Calleja

See More
Publication Type
Journal
Publication Sub Type
Announcements
Title
St. Luke's Medical Journal
Frequency
Semi-Annual
Publication Date
January-June 2004
Volume
2
Issue
1
Page(s)
3-10
LocationLocation CodeAvailable FormatAvailability
HERDIN website Abstract External Link (View)
Philippine Council for Health Research and Development Library Fulltext Print Format (Request Document)
Philippine Council for Health Research and Development Library Fulltext pdf (Request Document)
1. Kempner, W . "Treatment of kidney disease and hypertensive vascular disease and rice diet" N Carolina Med J 5, 125-133, 1944
2. Prior, I . Isolated groups, particular population and their contribution. In Cardiology: Hayase S, Murao S, eds. Excerpta Medica Amsterdam: 1979. 131-136.
3. Darne, B, et al. . "Pulsatile versus steady component of blood pressure: A cross-sectional analysis and a perspective analysis on cardiovascular morbidity" Hypertension 13, 392-400, 1989
4. ORourke, M . "Arterial stiffness, systolic blood pressure and logical treatment of arterial pressure" Hypertension 15, 339-347, 1990
5. Franklin, S S, et al.. "Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Study" Circulation 103, 1245-1249, 2001
6. Mitchell, G E, Izzo, J L. Evaluation of arterial stiffness. Hypertension Primer Philadelphia: Lippincott Williams & Wilkins, 2003. 351. (3rd Editio)
7. Bakris, G L, Mensah, G A. "Pathogenesis and clinical physiology of hypertension" Cardio Clin 20, 195-206, 2002
8. "Joint National Committee. The third report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure" Arch Intern Med 144, 1045-1057, 1984
9. Mackenzie, J . Principles of Diagnosis and Treatment of Heart Affections London: Oxford, 1926. 189.
10. Dluhy, R G. Monogenic determinant of blood pressure. Hypertension Primer Philadelphia: Lippincott Williams & Wilkins, 2003. 224. (3rd Editio)
11. Arnett, D K. Heritability of hypertension and target organ damage. Hypertension Primer Philadelphia: Lippincott, Williams and Wilkins, 2003. 227. (3rd Editio)
12. Hunt, S C. Genetics and family history of hypertension. Hypertension Primer Philadelphia: Lippincott Williams & Wilkins, 2003. 218. (3rd Editio)
13. Ravogli, A, et al. . "Early 24 hour blood pressure elevation in normotensive subjects with parental hypertension" Hypertension 16, 491-497, 1990
14. Verdecchia, P . "Prognostic value of ambulatory blood pressure" Hypertension 35, 844-851, 2000
15. Kannel, W B, Gordon, T , Schwartz, M J. "Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham Study" Am J Cardiol 27, 335-346, 1971
16. "Guidelines Subcommittee" World Health Organization-International Society of Hypertension 34, 181-186, 1999
17. Riva, Rocci S. "La technica della sfigmomanometria" Gazetta Medici di Torino 10, 181-191, 1897
18. Resnick, L . "The cellular ionic basis of hypertension and allied conditions" Prog Cardiovasc Dis 42, 1-22, 1999
19. Page, I H. "Hypertension research - a memoir 1920-1960" Hypertension 16, 199-200, 1999
20. McKusick, V A. Cardiovascular Sound in Health and Disease The Williams & Wilkins Co. , 1958. 29.
21. Armstrong, P W. "Do guidelines influence practice?" Heart 89, 349-352, 2003
22. Ruzicka, M , Leener, FH H. Monotherapy versus combination therapy as first line treatment of uncomplicated arterial.
23. Stamler, J . "The INTERSALT study: Background, methods, findings and implications" Am J Clin Nutr 65, 6255-6425, 1997
24. Simpson, F O. "Salt saga continued (letter)" Br Med J 297, 684, 1988
25. Swales, J D. "Salt saga continued (editorial)" Br Med J 297, 307-308, 1988
26. Elliott, P . Salt and blood pressure. Hypertension Primer Philadelphia: Lippincott Williams & Wilkins, 2003. 277. (3rd Editio)
27. Stamler, J, et al. . "INTERSALT study findings - public health and medical care implications" Hypertension 14, 570-577, 1989
28. Kuller, L H, et al.. "Unexpected results of treating hypertension in men with electrocardiographic abnormalities. A critical analysis" Circulation 73, 1114-1123, 1986
29. Hansson, L, et al. . "For Swedish trial in old patients with hypertension" Cardiovasc Drug Ther 4, 1253-1256, 1990
30. "SHEP Cooperative Research Group for systolic hypertension in the elderly program" JAMA 265, 3255-3264, 1991
31. Staessen, J, et al. . "Nitrendipine in older patients with isolated systolic hypertension: Second progress report on the SYST-EUR Trial" J Human Hypetens 7, 265-271, 1993
32. Voko, Z, et al. . "J-shaped relation between blood pressure and stroke in treated hypertensives" Hypertension 34, 1181-1185, 1999
33. Klein, W W. "Current and future relevance of guidelines" Heart 87, 497-500, 2002
34. Safar, M E. "Epidemiological findings imply that goals for drug treatment of hypertension need to be revised" Circulation 103, 1188-1190, 2001
35. Camussi, A , Bianchi, G . "Genetics of essential hypertension - from unimodal bimodal controversy to molecular technology" Hypertension 12, 620-628, 1988
36. "Reports of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: " JNC I JAMA 1977, 237:255-261; JNC II Arch Intern Med 1980, 140:1280-1285; JNC III Arch Intern Med 1984, 144:1045-1057; JNC IV Arch Intern Med 1988,148:1023-1038; JNC V Arch Intern Med 1993, 153:154-183; JNC VI Arch Intern Med 1997, 157:2413-2446; JNC VII ,
37. Wood, J E, Battey, L L. "The natural history of diastolic hypertension and the effects of blood pressure regulation" Am J Cardiol 9, 675-679, 1962
38. Wood, P . Diseases of the Heart and Circulation Philadelphia: JB Lippincott Co, 1956. 761-805. (2ns Editio)
39. He, J , Whelton, P K. "Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease" J Hypertens 17 (suppl , S7-13, 1999
40. Redgrave, J E, et al.. "Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition" J Clin Invest 75, 1285-1290, 1985
41. Romero, J C, et al.. "Multiple effects of calcium entry blockers in renal function in hypertension" Hypertension 10, 140-151, 1987
42. Calleja, H B. In Defense of the Physician Manila: Raintree Trading Inc., 1999. 13-17.
43. Mancilha-Carvalho, J J, et al.. "Blood pressure in four remote populations in the INTERSALT study" Hypertension 14, 238-246, 1989
44. Gubner, R S. "Systolic hypertension: A pathogenic entity - significance and therapeutic considerations" Am J Cardiol 9, 773-776, 1962
45. Cohn, J N. "Presidential address" 1988. Amsterdam: International Society of Hypertension,
46. Weinberger, M H. "Optimizing cardiovascular risk reduction during antihypertensive therapy" Hypertension 16, 201-211, 1990
47. Whelton, P K. Potassium and blood pressure. Hypertension Primer Philiadelphia: Lippincott Williams & Wilkins, 2003. 895. (3rd Editio)
48. Pickering, G . "Hypertension - definitions, natural histories and consequences" Am J Med 52, 1213-1226, 1972
49. Weinberger, M H. Salt sensitivity . Hypertension Primer Philadelphia: Lippincott Williams & Wilkins, 2003. 133.

Copyright © One Window Project 2018. All rights reserved.